Preliminary Scientific Programme

Thursday, January 30, 2025

Opening                                 

Time Presentation Title Speaker
08:30-08:45
 Opening & Objectives
Paola Anna Erba
Sofia C. Vaz
Karolien Goffin

 

Thursday, January 30, 2025

Assessing Suspicious Breast Lesions With Imaging (T&N Staging)

Chairpersons: TBC

Time Presentation Title
08:47-09:05 Essential Information Needed for Clinical Decision
09:08-09:26 State of the Art in Pathology
09:29-09:47 Optimal Diagnosis of Breast Cancer With Radiologic Imaging (T & N Staging)
09:50-10:08 Indications for Molecular Breast Imaging (Scintigraphy and PET)
10:11-10:29
Expectations from Lymphoscintigraphy and Imaging-Guided Surgery
11:00-11:15 Controversy: How to Position Molecular Imaging in Evaluating
11:16-11:23
In Favour
11:24-11:31
Against
11:32-11:47
Current Evidence
11:48-11:58
Questions & Answers
12:00-13:00
Consensus on Imaging for Suspicious Breast Lesions evaluation (T&N Staging)

 

Thursday, January 30, 2025

Baseline Systemic Staging of Breast Cancer (M Staging) 

Chairpersons: TBC

Time Presentation Title
14:00-14:20 Essential Information from Conventional Imaging for M Staging
14:21-14:41 Indications for PET with FDG
14:42-15:02 Indications for PET with FES
15:03-15:18 Molecular Characterization with wbMRI (Special Clinical Needs & Bone Assessment)
15:19-15:35 
‘In Vivo’ Molecular Characterization Using PET
16:00-16:15
Consensus on Imaging for Biochemical Recurrence of Prostate Cancer
16:16-16:23
In Favour
16:24-16:31
Against
16:32-16:47
Current Evidence
16:48-16:58
Questions & Answers 
17:00-18:00
Consensus on Imaging for Baseline Systemic Staging of Breast Cancer (M Staging) 

 

Friday, January 31, 2025

Assessing Systemic Treatment Response with Imaging

Chairpersons: TBA

Time Presentation Title
09:00-09:18 Clinical Assessment of Treatment Response in Early Breast Cancer
09:20-09:38 Imagiological Assessment of Treatment Response in Early Breast Cancer
09:40-09:58 Clinical Assessment of Treatment Response in Advanced Breast Cancer
10:00-10:18 Radiological Criteria to Assess Treatment Response in Advanced Breast Cancer  
10:20-10:35 PET in Assessing Treatment Response in Advanced Breast Cancer    
11:00-11:15 Controversy: Is FDG PET/CT Ready to Assess Therapy Response?
11:16-11:23 In Favour
11:24-11:31 Against
11:32-11:47 Current Evidence 
11:48-12:58 Questions & Answers
12:00-13:00 Consensus on Imaging for Assessing Systemic Treatment Response 

 

Friday, January 31, 2025

Assessing Systemic Recurrence with Imaging

Chairpersons: TBA

Time Presentation Title
14:00-14:20 When to Suspect Tumour Recurrence
14:25-14:45 The Challenge of Oligometastatic Disease  
14:50-15:10  Assessing Recurrence with Conventional Imaging
15:15-15:35 Assessing Recurrence with PET/CT and PET/MRI
16:00-16:15 Controversy: Is PET Ready to Assess Recurrence in all Breast Cancer Subtypes?  
16:16-16:23
In Favour
16:24-16:31 Against
16:32-16:47 Current Evidence   
16:48-16:58 Questions & Answers
17:00-18:00 Consensus on Imaging for Assessing Breast Cancer Systemic Recurrence

 

Saturday, February 1, 2025

Future Imaging Challenges & Developments in Breast Cancer

Chairpersons: TBA

Time Presentation Title
09:00-09:15 Revolutionary Clinical Targets Used in Medical Treatment
09:17-09:35 Revolutionary Clinical Targets Used in Medical Treatment
09:37-09:55 New Targets Used in Radiopharmaceuticals
09:57-10:15 Bone Pain Palliation & Theranostics Possibilities
10:17-10:35 Impact of PET-based Radiation Therapy Planning
11:00-11:15 Controversy: What Is Still Needed to Move Theranostics Further in Breast Cancer?
11:15-12:15 Overall Consensus
12:15-12:30 Consensus on ‘Relevant Factors to Build a Consensus’  
12:30-12:50 Summary of Results and Debate with all Participants
12:50-13:00 Future Directions & Closing Remarks